SEVENTH INTERNATIONAL CONFERENCE 
ON BIPOLAR DISORDER

June 7-9, 2007

David L. Lawrence Convention Center
Pittsburgh, Pennsylvania

Overview & Faculty | Multimedia Presentions | Mogens Schou Awards | Posters | Registration | Travel & Hotel
ICBD Archives | CDI2008 | UPMC Psychiatry | Contact Us | Home

Welcome and Overview

The International Conference on Bipolar Disorder has become the most important and well attended meeting focusing on bipolar disorder.  Clinicians, researchers, patients and consumers from around the world will again come together for this three-day conference to share their clinical expertise, research findings and personal experiences with the goal of improving the quality of life of those living with bipolar disorder.  The meeting will occur at the David L. Lawrence Convention Center located in the heart of downtown Pittsburgh, PA.  The sixth annual meeting (June, 2005) was the first to be held in the new location.  Feedback from conference participants indicated that this location worked well with the structure of the conference and so we are again holding the conference at this location.

The conference will focus on the following topics: classifying bipolar disorders; treatment of bipolar depression; advances in neurobiology and genetics; psychoeducation and psychotherapy; medical risk prevention and intervention; and international perspective on bipolar disorder.

Multiple concurrent sessions on clinical trial data, genetics and neuroimaging, psychosocial treatments, childhood bipolar disorder, diagnostic issues, substance abuse, medical comorbidity and women’s reproductive health will be held throughout the meeting.  The conference will be held June 7, 8, and 9, 2007.  As in the past, poster sessions will be held on the evenings of June 7 and 8.  The well received “Rapid Communications” sessions will also be repeated this year.

The third day of the conference will include plenary sessions on international perspectives as well as a  focused session on the future of diagnostic criteria in bipolar disorder.  There will be an advocacy/researcher dialogue, and advanced psychotherapy workshops on cognitive behavioral therapy, family focused therapy, and interpersonal and social rhythm therapy.

We look forward to your active participation in the conference.

David J. Kupfer, MD

Educational Objectives

At the conclusion of this program, participants should be able to:

• Describe new approaches to the pharmacotherapy and psychotherapy of bipolar disorder.
• Distinguish between the issues related to short- and long-term treatment of bipolar depression.
• Explain key issues from the update on neuroscience and clinical advances in bipolar disorder.
•  Discuss the life-span implications of bipolar disorder.

Who Should Attend

Presentations during the first two days of the conference will be technical and geared toward academic researchers and research-oriented clinicians. Psychiatrists, psychologists, neuroscientists and pharmacologists interested in bipolar disorder should find the content of this first phase of the conference useful in their research and clinical practice.

The sessions on the third day of the conference will be appropriate to audiences that include psychiatrists, psychologists, social workers, nurses, and other mental health care workers, as well as individuals who have bipolar disorder and their families.  Several of the Saturday workshops will be focused on issues relevant to advocacy for bipolar disorder.

Course Directors

Ellen Frank, PhD
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Samuel Gershon, MD
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

David Kupfer, MD
University of Pittsburgh School of Medicine
Pittsburgh Pennsylvania

Michael E. Thase, MD
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania      

International Planning Committee

Valentim Gentil, MD, PhD
University of Sao Paulo Medical School
Sao Paulo, Brazil

Giovanni de Girolamo, MD
Department of Mental Health
Bologna, Italy

Guy Goodwin, MD
University Department of Psychiatry
Warneford Hospital
Oxford, United Kingdom

Fouzia Laghrissi-Thode, MD
F. Hoffmann-La Roche Ltd.
Basel, Switzerland
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania

Bruno Muller-Oerlinghausen, DrMed
Freie Universitaet Berlin
Berlin, Germany

Per Vestergaard, DrMedSc
Aarhus University, Psychiatric Hospital
Risskov, Denmark

Eduard Vieta, MD, PhD
University of Barcelona
Barcelona, Spain

Lakshmi N. Yatham, MB, FRCPC
University of British Columbia
Vancouver, British Columbia, Canada

Faculty

Brenda Bergeson, MD
Depression and Bipolar Support Alliance (DBSA)
Chicago, Illinois

Rodney Elgie
GAMIAN-Europe
Kent, United Kingdom

Lisa C. Goodale, MSW
Depression and Bipolar Support Alliance (DBSA)
Chicago, Illinois

Matthew G. Mattson, MS
Depression and Bipolar Support Alliance (DBSA)
Chicago, Illinois

Stephen Propst, MBA
Depression and Bipolar Support Alliance (DBSA)
Chicago, Illinois

Rapid Communications Sessions Speakers:

Martin Alda, MD, FRCPC
McGill University
Montreal, Canada

Stein Andersson, PhD
Rikshospitalet
Oslo, Norway 

Michael Berk, MD, PhD
University of Melbourne
Victoria, Australia

Nick Craddock, MD, PhD, FRCP
On behalf of 
Wellcome Trust Case Control Consortium
Cardiff University
United Kingdom

Faith Dickerson, PhD
Sheppard Pratt Health System
Baltimore, MD

Sophia Frangou, MD, PhD
Institute of Psychiatry
London, United Kingdom

Richard Keefe, PhD
Duke University Medical Center
Durham, North Carolina, USA

Marion Leboyer, MD, PhD
XII Paris University
Crétil, France

Rasmus W. Licht, MD, PhD
Aarhus University Psychiatric Hospital
Risskov, Denmark

Michael J. Ostacher, MD, PhD
Harvard Medical School
Massachusetts General Hospital
Boston, Massachusetts 

Mauricio Tohen, MD, DrPh, MBA
On behalf of 
The International Society for Bipolar Disorders
Indianapolis, Indiana

Inge van Rossum, MSc
Lilly Netherlands
Houtan, Netherlands

Carlos A. Zarate, Jr., MD
National Institute of Mental Health
Bethesda, Maryland

John E. Zeber, PhD
South Veterans Health Care System
San Antonio, Texas
 

In accordance with Accreditation Council for Continuing Medical Education Requirements on disclosure, information about relationships of presenters with commercial interests (if any) will be included in materials which will be distributed at the time of the conference.

If you are experiencing any problems accessing this information please e-mail Maria Pena-Jordan at penajordanmi@upmc.edu

Last updated 10/10/2007

© 2006 The Department of Psychiatry, University of Pittsburgh School of Medicine